ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,117Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 121

$717K Total Retail Price of All Prescriptions

Rank: 15 out of 121

426 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 426 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

35% of this provider’s 426 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 7,560 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $171 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 781 387 S3 1 4
LEVOTHYROXINE SODIUM 527 359 2 13
SIMVASTATIN 366 253 3 16
LIOTHYRONINE SODIUM 346 222 10 4 52
LISINOPRIL 336 248 5 19
OMEPRAZOLE 324 204 6 8
CARVEDILOL 322 269 7 46
FAMOTIDINE 281 194 8 33
GABAPENTIN 273 138 9 7
FUROSEMIDE 268 207 10 24
POTASSIUM CHLORIDE 233 191 11 42
AMLODIPINE BESYLATE 213 162 12 29
METOPROLOL TARTRATE 191 110 13 28
METFORMIN HCL 176 89 14 34
WARFARIN SODIUM 165 114 15 53
METHOTREXATE 155 98 16 1
GLIPIZIDE 153 81 17 79
ISOSORBIDE MONONITRATE ER 142 92 18 84
ROPINIROLE HCL 138 81 19 86
CYMBALTA 126 64 20 21
DONEPEZIL HCL 124 109 21 67
PRAVASTATIN SODIUM 122 51 22 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 68 23 54
GEMFIBROZIL 115 73 24 90
RANITIDINE HCL 108 37 25 68
ATENOLOL 106 75 26 93
PREDNISONE 103 64 27 2
CEPHALEXIN 93 42 28 82
TRAMADOL HCL 93 66 28 5
PROAIR HFA 91 34 30 65
LOVASTATIN 89 54 31 79
CLONIDINE HCL 88 76 32 77
NAMENDA 85 71 33 88
CLOPIDOGREL 84 40 34 62
AMITRIPTYLINE HCL 83 55 R 35 40
TAMSULOSIN HCL 82 53 36 78
FENTANYL 80 60 S2 37 26
POLYETHYLENE GLYCOL 3350 80 28 37 82
SERTRALINE HCL 79 65 39 56
CYCLOBENZAPRINE HCL 77 22 R 40 14
HYDROCHLOROTHIAZIDE 77 38 40 50
NOVOLOG 77 62 40 102
AZITHROMYCIN 76 35 43 103
ALLOPURINOL 70 51 44 15
OXYBUTYNIN CHLORIDE 68 39 45 74
SPIRIVA 68 35 45 105
DIGOXIN 66 51 47 109
HYDROXYCHLOROQUINE SULFATE 64 46 48 3
ESCITALOPRAM OXALATE 62 41 49 111
METHYLPREDNISOLONE 62 32 49 32
LANTUS 58 48 51 115
METOPROLOL SUCCINATE 58 55 51 63
PLAVIX 54 31 53 92
QVAR 53 0 54 125
RISPERIDONE 51 38 55 126
ISOSORBIDE DINITRATE 51 43 55 126
BUMETANIDE 50 45 57 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.